Is DCDC2 p.Ala61= (c.183C>T) pathogenic?

DCDC2 p.Ala61= (c.183C>T) is classified Benign/Likely benign in DCDC2 (ClinVar, Multiple submitters, 4 submitters; last evaluated 2026-02-01). Common (popmax 6.86%, mid) — too common for a highly-penetrant pathogenic allele; Associated with isolated neonatal sclerosing cholangitis.

What condition is associated with DCDC2 p.Ala61= (c.183C>T)?

DCDC2 p.Ala61= (c.183C>T) is associated with isolated neonatal sclerosing cholangitis, autosomal recessive nonsyndromic hearing loss 66 (ClinVar).

How is Isolated neonatal sclerosing cholangitis inherited?

Typically Autosomal recessive (Orphanet). A genetic counselor can assess individual risk for a family.

DCDC2 p.Ala61=

Q: How common is DCDC2 p.Ala61= (c.183C>T) in the general population?

DCDC2 p.Ala61= (c.183C>T) is common (popmax 6.86%, mid) — too common for a highly-penetrant pathogenic allele (gnomAD).

c.183C>T · rs33943110 · VCV466323

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 4 submitters

gnomAD v4.1

Common

common (popmax 6.86%, mid) — too common for a highly-penetrant pathogenic allele

Conditions

isolated neonatal sclerosing cholangitis

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
REVEL	0.12	moderately benign-leaning
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -3.7	GERP -3.8
Overall
CADD	5.334	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 6.86% Middle Eastern · 416/6,062 alleles

Filtering AF 6.32% ClinGen BA1/BS1 input FAF95, joint · FAF99 6.1%

Overall 5.37% 86,591/1,613,326 alleles · common

Ancestry group	Frequency	1 in
Amishnot grpmax-eligible	8.68%	12
Ashkenazi Jewishnot grpmax-eligible	7.05%	14
Middle Easterngrpmax	6.86%	15
European (non-Finnish)	5.96%	17
Remaining individualsnot grpmax-eligible	5.6%	18
South Asian	5.22%	19
Admixed American	3.89%	26
Finnishnot grpmax-eligible	3.36%	30
African / African-American	1.21%	82
East Asian	0.245%	408

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: DCDC2
Protein: p.Ala61=
Coding: c.183C>T
MANE Select: NM_016356
dbSNP: rs33943110
Type: single nucleotide variant
Location: chr6:24357568 (GRCh38)
Gene constraint: LOEUF 1.062 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 63.93 · 1 PDB
Residue 61: the doublecortin 1 domain

Full DCDC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

isolated neonatal sclerosing cholangitis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: autosomal recessive nonsyndromic hearing loss 66

For Isolated neonatal sclerosing cholangitis (Orphanet):

Inheritance: Autosomal recessive
Onset: Neonatal

Similar variants

DCDC2 c.294-2A>G Pathogenic ★★ same condition
DCDC2 c.349-2A>G Pathogenic ★★ same condition
DCDC2 c.705-2A>G Pathogenic ★★ same condition
DCDC2 p.Leu297Ter Pathogenic ★★ same condition
DCDC2 p.Met1Arg Pathogenic/Likely pathogenic ★★ ⚠ same condition
DCDC2 p.Ser128Ter Pathogenic/Likely pathogenic ★★ same condition
DCDC2 p.Ala384Gly Uncertain significance ★★ ⚠ same condition
DCDC2 p.Ala93Asp Uncertain significance ★★ ⚠ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dcdc2-p-ala61 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown